Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

JAAD Case Rep. 2021 Nov:17:18-20. doi: 10.1016/j.jdcr.2021.09.009. Epub 2021 Sep 22.

Authors

Jose W Ricardo¹, Shari R Lipner¹

Affiliation

¹ Department of Dermatology, Weill Cornell Medicine, New York, New York.

No abstract available

Keywords: Beau lines; COVID-19; adverse reaction; mRNA, messenger RNA; nail psoriasis; nails; onycholysis; psoriasis; vaccine.

Publication types

Case Reports